XML 38 R18.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

(LOSS) INCOME PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC. | 9 Months Ended
--- | ---
Oct. 31, 2019
(LOSS) INCOME PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC. |
(LOSS) INCOME PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC. | NOTE 12 – (LOSS) INCOME PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC. Basic and diluted (loss) income per share are computed as follows (shares in thousands except in note(1) below the charts):
|  | Three Months Ended October 31,
|  | 2019 |  | 2018
Net (loss) income attributable to the stockholders of Argan, Inc. |  | $ | (6,855) |  | $ | 32,434
Weighted average number of shares outstanding - basic |  |  | 15,633 |  |  | 15,569
Effects of stock awards (1) |  |  | — |  |  | 133
Weighted average number of shares outstanding - diluted |  |  | 15,633 |  |  | 15,702
Net (loss) income per share attributable to the stockholders of Argan, Inc. |  |  |  |  |  |
Basic |  | $ | (0.44) |  | $ | 2.08
Diluted |  | $ | (0.44) |  | $ | 2.07
|  | Nine Months Ended October 31,
|  | 2019 |  | 2018
Net (loss) income attributable to the stockholders of Argan, Inc. |  | $ | (35,501) |  | $ | 54,243
Weighted average number of shares outstanding - basic |  |  | 15,617 |  |  | 15,568
Effects of stock awards (1) |  |  | — |  |  | 117
Weighted average number of shares outstanding - diluted |  |  | 15,617 |  |  | 15,685
Net (loss) income per share attributable to the stockholders of Argan, Inc. |  |  |  |  |  |
Basic |  | $ | (2.27) |  | $ | 3.48
Diluted |  | $ | (2.27) |  | $ | 3.46
| (1) |  | For the three and nine months ended October 31, 2019, the weighted average numbers of shares determined on a dilutive basis excludes the effects of outstanding stock awards. All common stock equivalents are considered to be antidilutive for these periods as the Company incurred net losses in each period. The weighted average numbers for the three and nine months ended October 31, 2018 exclude the effects of antidilutive stock options covering 581,500 shares for each period; the options had exercise prices per share in excess of the average market price per share for each period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration